NCT00816413 2023-08-14Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological CancerUniversity of NebraskaPhase 1/2 Withdrawn
NCT00363090 2013-09-20Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 1/2 Unknown84 enrolled